Latest Articles

Publication Date
History of infertility and risk of endometrial cancer in the Women's Health Initiative.

Several studies have suggested an association between infertility and risk of endometrial cancer. However, most studies have evaluated this relationship in premenopausal people, yet the mean age of endometrial cancer …

Published: Sept. 30, 2024, midnight
Postmarketing adverse events of tamoxifen in male and female patients with breast cancer.

Tamoxifen (TAM), a selective estrogen receptor (ER) modulator, has received approval for use in patients with breast cancer (BC) exhibiting positive ER expression. Given the widespread clinical use of TAM, …

Published: Sept. 21, 2024, midnight
Zearalenone promotes endometrial cancer cell migration and invasion via activation of estrogen receptor-mediated Rho/ROCK/PMLC signaling pathway.

Zearalenone (ZEA), has emerged as a potential endocrine-disrupting chemical (EDC). Previous results show ZEA effects on endometrial stromal cell apoptosis, migration, and growth of endometriosis. Despite the reported presence of …

Published: Sept. 19, 2024, midnight
Ultrasound Screening Often Misses Endometrial Cancer in Black Females - Healthline

Ultrasound Screening Often Misses Endometrial Cancer in Black Females Healthline

Published: July 9, 2024, 7 a.m.
The Latest on Targeted Agents, Immunotherapy for Endometrial Cancer - Medpage Today

The Latest on Targeted Agents, Immunotherapy for Endometrial Cancer Medpage Today

Published: July 5, 2024, 7 a.m.
Dostarlimab/Chemo Shows OS Benefit Regardless of MMR Status in Endometrial Cancer - OncLive

Dostarlimab/Chemo Shows OS Benefit Regardless of MMR Status in Endometrial Cancer OncLive

Published: July 3, 2024, 7 a.m.
Transvaginal ultrasonography unreliable in identifying endometrial cancer for Black women - Healio

Transvaginal ultrasonography unreliable in identifying endometrial cancer for Black women Healio

Published: July 3, 2024, 7 a.m.
Durvalumab-Based Regimen Improves Overall Response Rate in Endometrial Cancer - www.oncnursingnews.com/

Durvalumab-Based Regimen Improves Overall Response Rate in Endometrial Cancer www.oncnursingnews.com/

Published: July 2, 2024, 7 a.m.
Ultrasound May Be Unreliable in Spotting Endometrial Cancer in Black Women - HealthDay

Ultrasound May Be Unreliable in Spotting Endometrial Cancer in Black Women HealthDay

Published: July 2, 2024, 7 a.m.
Durvalumab Plus Olaparib Approaches EU Approval for pMMR Advanced or Recurrent Endometrial Cancer - OncLive

Durvalumab Plus Olaparib Approaches EU Approval for pMMR Advanced or Recurrent Endometrial Cancer OncLive

Published: July 1, 2024, 7 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!